Speaker illustration

Doctor Kiran Bapatla

Novartis, Hyderabad (India)

Efficacy and safety of valsartan in children aged 1-5 years with hypertension, with or without chronic kidney disease: A 6-week randomised, multicentre, double-blind study followed by open-label phase

Event: ESC Congress 2019

Topic: Clinical

Session: Hypertension treatment: drugs and devices


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb